FDA’s Policing of Dietary Supplements
Orange County, CA - February 13th, 2019 - In the past 25 years, the Dietary Supplement Industry has evolved consumers choices from its initial 4,000 products to 80,000; making the industry worth $40 billion. The Food and Drug Administration (FDA) announced plans Monday to step up its policing of Dietary Supplements, which it said has grown into a $40 billion industry with more than 50,000 products.
The agency warned 17 companies for illegally making claims about their products' ability to treat serious diseases which included Alzheimer's disease and cancer. The companies, which included Gold Crown Natural Products, Pure Nootropics, TEK Naturals, and Sovereign Laboratories, have 15 business days to respond to the FDA's letters.
Approximately, 75 percent of Americans regularly take dietary Supplements. The supplement market might have outpaced the agency's ability to properly regulate the volume and variety of products hitting the market. The FDA is working toward more rapid response methods of issuing consumer warnings and cease the production and distribution of products marketed using fraudulent claims to prevent or cure conditions that cannot be treated with over-the-counter supplements.
Related Articles
Dietary supplements, including vitamins, are regulated more like foods than drugs. They can make claims similar to what’s on cereal boxes or snack bars, but they can’t contain drug ingredients or make claims about treating diseases like Alzheimer’s, cancer or diabetes. "As the popularity of supplements has grown, so have the number of entities marketing potentially risky products or making unproven or misleading claims about the health benefits they may deliver," FDA Commissioner Scott Gottlieb said.
According to a statement by Dr. Scott Gottlieb, the FDA declared to update its policies on dietary supplements, which promises “one of the most significant modernizations of dietary supplement regulation and oversight in more than 25 years.”
The FDA aims to quickly alert the public to avoid buying products that may contain supplements with unlawful or potentially dangerous ingredients. The FDA said it would continue to roll out plans in the next few months and that it plans to open communication up to the contributing parties and the public.
Contact Ampronix:
Email: [email protected]
International Sales: +1 949-273-8000
Domestic Sales: 1800-400-7972 for US and Canada
Follow Us:
Facebook, Twitter, LinkedIn
Share This Article:
View our Product Catalog Online Here
About Ampronix
Ampronix is a renowned authorized master distributor of the medical industry's top brands as well as a world-class manufacturer of innovative technology. Since 1982, Ampronix has been dedicated to meeting the growing needs of the medical community with its extensive product knowledge, outstanding service, and state-of-the-art repair facility. Ampronix prides itself on its ability to offer tailored, one-stop solutions at a faster and more cost-effective rate than other manufacturers. Ampronix is ISO 13485:2016, and ANSI/ESD S20.20-2014 certified.
